Diabetes: Certain J&J insulin pumps destined to fail over software issue

January 22, 2013 by MassDevice staff

Johnson & Johnson subsidiary Animus Corp. warns that certain of its Animas insulin pumps will become defunct at the stroke of midnight on December 31, 2015.

Example Animus insulin pump

Johnson & Johnson (NYSE:JNJ) subsidiary Animas Corp. warned European regulators that certain of the company's ambulatory insulin pumps contain a software flaw that will render the devices defunct on the stroke of midnight on December 31, 2015.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp